https://www.novumpr.nl/2019/09/10/vbi-vaccins-kondigt-fase-2a-klinische-evaluatie-van-vbi-1901-kandidaat-kankervaccin-aan-in-combinatie-met-het-as01b-adjuvant-system-van-gsk-bij-terugkerende-patienten-met-een-glioblastoma/?utm_source=rss&utm_medium=rss&utm_campaign=vbi-vaccins-kondigt-fase-2a-klinische-evaluatie-van-vbi-1901-kandidaat-kankervaccin-aan-in-combinatie-met-het-as01b-adjuvant-system-van-gsk-bij-terugkerende-patienten-met-een-glioblastoma NovumPR press releases Tue, 10 Sep 2019 11:21:22 +0000 hourly 1 https://wordpress.org/?v=6.8.3